|
Name |
Dimethyl tetrasulfide
|
Molecular Formula | C2H6S4 | |
IUPAC Name* |
(methyltetrasulfanyl)methane
|
|
SMILES |
CSSSSC
|
|
InChI |
InChI=1S/C2H6S4/c1-3-5-6-4-2/h1-2H3
|
|
InChIKey |
NPNIZCVKXVRCHF-UHFFFAOYSA-N
|
|
Synonyms |
Dimethyl tetrasulfide; Tetrasulfide, dimethyl; 5756-24-1; Dimethyl tetrasulphide; (methyltetrasulfanyl)methane; 1,4-Dimethyltetrasulfane; 1,4-Dimethyltetrasulfide; dimethyltetrasulfane; EINECS 227-278-8; Dimethyl pertetrasulfide; Methyl tetrasulfide, 8CI; 2,3,4,5-Tetrathiahexane; 1,4-Dimethyltetrasulfane #; SCHEMBL565279; DTXSID0063997; methyldisulfanyldisulfanyl-methane; AM806645; FT-0654011; 756D241; A831505; Q63398078
|
|
CAS | 5756-24-1 | |
PubChem CID | 79828 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 158.3 | ALogp: | 1.8 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 101.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 6 | QED Weighted: | 0.453 |
Caco-2 Permeability: | -4.827 | MDCK Permeability: | 0.00002150 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.841 | Plasma Protein Binding (PPB): | 28.21% |
Volume Distribution (VD): | 1.007 | Fu: | 56.84% |
CYP1A2-inhibitor: | 0.942 | CYP1A2-substrate: | 0.917 |
CYP2C19-inhibitor: | 0.982 | CYP2C19-substrate: | 0.872 |
CYP2C9-inhibitor: | 0.86 | CYP2C9-substrate: | 0.656 |
CYP2D6-inhibitor: | 0.089 | CYP2D6-substrate: | 0.491 |
CYP3A4-inhibitor: | 0.008 | CYP3A4-substrate: | 0.318 |
Clearance (CL): | 9.917 | Half-life (T1/2): | 0.146 |
hERG Blockers: | 0.352 | Human Hepatotoxicity (H-HT): | 0.109 |
Drug-inuced Liver Injury (DILI): | 0.185 | AMES Toxicity: | 0.276 |
Rat Oral Acute Toxicity: | 0.833 | Maximum Recommended Daily Dose: | 0.101 |
Skin Sensitization: | 0.961 | Carcinogencity: | 0.229 |
Eye Corrosion: | 0.984 | Eye Irritation: | 0.996 |
Respiratory Toxicity: | 0.99 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000531 | 0.706 | D08HVE | 0.091 | ||||
ENC000417 | 0.471 | D0X5SD | 0.074 | ||||
ENC000713 | 0.174 | D0U3IG | 0.071 | ||||
ENC000522 | 0.160 | D0E0SW | 0.068 | ||||
ENC000656 | 0.133 | D0C1QZ | 0.065 | ||||
ENC000355 | 0.103 | D0F1GS | 0.065 | ||||
ENC000524 | 0.103 | D0Z4NI | 0.065 | ||||
ENC000286 | 0.100 | D0XB8P | 0.061 | ||||
ENC000689 | 0.100 | D0ZK8H | 0.059 | ||||
ENC005509 | 0.090 | D02KJX | 0.059 |